Next-Generation Water-Soluble Cannabinoid and/or Terpene Extract System
Legal Citation
Summary of the Inventive Concept
A futuristic system for personalized, targeted, and efficient delivery of water-soluble cannabinoid and/or terpene extracts, leveraging cutting-edge technologies to revolutionize the industry.
Background and Problem Solved
The original patent introduced a water-soluble, powdered cannabinoid and/or terpene extract, but it has limitations in terms of bioavailability, customization, and targeted delivery. The new inventive concept addresses these limitations by incorporating bioavailability enhancers, genetic profiling, nano-particle delivery systems, and real-time monitoring, thereby providing a more efficient and effective solution.
Detailed Description of the Inventive Concept
The system comprises a water-soluble, powdered cannabinoid and/or terpene extract, which can be customized based on an individual's genetic profile to optimize the cannabinoid and/or terpene ratio. The extract is then loaded onto a nano-particle delivery system, designed to target specific cells or tissues in the body, increasing the efficacy of the extract. The system also includes a device for administering the extract, such as a dry powder inhaler utilizing a piezoelectric actuator to generate a precise dosage. Furthermore, a wearable device tracks the individual's physiological response to the extract and communicates with a mobile application to adjust the dosage in real-time.
Novelty and Inventive Step
The new claims introduce several novel and non-obvious features, including the use of naturally-derived bioavailability enhancers, genetic profiling for personalized formulations, and real-time monitoring and adjustment of dosage. These advancements make the original patent's concept obsolete, as they provide a more efficient, targeted, and effective solution.
Alternative Embodiments and Variations
Alternative embodiments of the system could include different types of bioavailability enhancers, various methods for genetic profiling, and diverse nano-particle delivery systems. Additionally, the system could be adapted for use in different industries, such as pharmaceuticals, nutraceuticals, or cosmetics.
Potential Commercial Applications and Market
The next-generation water-soluble cannabinoid and/or terpene extract system has vast commercial potential in the pharmaceutical, nutraceutical, and cosmetic industries, offering a more efficient, targeted, and effective solution for delivering cannabinoids and terpenes. The market for such a system is expected to be substantial, driven by the growing demand for personalized and effective healthcare solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/185 |
| A | A61 | A61K9/107 |
| A | A61 | A61K47/02 |
| A | A61 | A61K47/36 |
| A | A61 | A61K47/40 |
| A | A61 | A61K47/44 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and nutraceutical formulation technologies, specifically cannabinoid extract preparation, drug delivery systems, and personalized medicine with a focus on advanced powder processing and bioavailability enhancement
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or related fields, possessing expertise in drug formulation, nanotechnology, and personalized medicine techniques, with working knowledge of cannabinoid extraction and delivery methodologies
Obviousness Rationale
A PHOSITA would recognize that the PTD represents predictable extensions of the source patent's core technology, applying known techniques in personalized medicine, nanotechnology, and drug delivery to enhance the original water-soluble cannabinoid extract concept. The variations represent logical combinations of existing technologies that would be apparent to someone skilled in pharmaceutical formulation and drug delivery systems. The incremental improvements in targeting, personalization, and administration are consistent with standard innovation practices in pharmaceutical technology.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,589 |
|---|---|
| Title | Water-soluble, powdered cannabinoid and/or terpene extract |
| Assignee(s) | MEDPHARM HOLDINGS, LLC |